Recent

% | $
Quotes you view appear here for quick access.

công ty Albany Molecular Research Message Board

  • notforsure notforsure Mar 4, 2005 7:08 AM Flag

    More of the same

    I have to agree with the previous poster in relation to amrisd and amrihd. More projects yet lower revenues.

    surprisingly, the organichem unit still is not hitting previous revenue levels.

    It will take some time for amri to recover and as they do, contract revenues will have to shifts to these new locations, if they don't, more of the same will occur.

    I think amri is a buy around 7.50, nothing higher. I have followed this security for some time and owned it on others. They overall story has changed.

    Oh, by the way, for those of you who believe its a biopharmaceutical company, go check your facts, it isn/'t.

    nfs

 
AMRI
19.635-0.585(-2.89%)2:13 PMEDT